Indeed, MTC is a neuroendocrine tumor and MZ‐CRC‐1 cells harbor the multiple endocrine neoplasia type 2B RET‐M918T mutation, transmitted in this disease as an autosomal dominant trait (Santoro et al., 1995). This evidence concerns the gene RET and neuroendocrine neoplasm.